New Delhi, Aug. 14 -- Doctors at a private hospital have reported an exceptional case of long-term survival in a patient with HER2-positive metastatic gastric adenocarcinoma, demonstrating how a personalised multidisciplinary treatment strategy combining targeted therapy, surgery, precision radiotherapy, and minimally invasive local ablative treatment can achieve prolonged disease control, even in advanced-stage gastric cancer.

The patient, a 65-year-old man, presented with abdominal pain, vomiting, significant weight loss, and metastatic disease involving the liver in 2018. Diagnostic evaluation confirmed HER2-positive metastatic gastric adenocarcinoma, a highly aggressive form of stomach cancer with a historically poor prognosis. Patie...